Inhibition of Interleukin-17 Promotes Differentiation of CD25– Cells Into Stable T Regulatory Cells in Patients With Autoimmune Hepatitis

Patients with autoimmune hepatitis (AIH) have reduced numbers and function of CD4+CD25highFOXP3+ T regulatory cells (Tregs). Tregs can be generated from CD25− (ngTreg) cells, which suppress the immune response less efficiently than Tregs. We investigated whether their differentiation into T-helper (...

Full description

Saved in:
Bibliographic Details
Published inGastroenterology (New York, N.Y. 1943) Vol. 142; no. 7; pp. 1526 - 1535.e6
Main Authors Longhi, Maria Serena, Liberal, Rodrigo, Holder, Beth, Robson, Simon C., Ma, Yun, Mieli–Vergani, Giorgina, Vergani, Diego
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Patients with autoimmune hepatitis (AIH) have reduced numbers and function of CD4+CD25highFOXP3+ T regulatory cells (Tregs). Tregs can be generated from CD25− (ngTreg) cells, which suppress the immune response less efficiently than Tregs. We investigated whether their differentiation into T-helper (Th)17 cells, an effector subset that has the same CD4+ progenitors as Tregs, accounts for the reduced suppressive functions of ngTregs. We investigated whether blocking interleukin (IL)-17 increased the immunosuppressive activity of Tregs. ngTregs were generated from 36 patients with AIH and 23 healthy subjects (controls). During Treg differentiation, expression of IL-17 was inhibited by physical removal of IL-17–secreting cells, exposure to recombinant transforming growth factor β or neutralizing antibodies against IL-6 and IL-1β (to promote differentiation of ngTregs vs Th17 cells), small inhibitory RNAs specific for the Th17 transcription factor RORC, or a combination of all these approaches. ngTregs from patients with AIH contained greater proportions of IL-17+ and RORC+ cells than Tregs from controls. All approaches to inhibit IL-17 increased expression of FOXP3 by ngTregs and their suppressive functions. Inhibition of IL-17 led to development of ngTregs that were phenotypically stable and did not acquire proinflammatory properties after exposure to IL-6 and IL-1β. Blocking Th17 allows ngTregs to differentiate into functionally stable immune inhibitory cells; this approach might be developed for therapy of patients with AIH.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0016-5085
1528-0012
1528-0012
DOI:10.1053/j.gastro.2012.02.041